高级检索
当前位置: 首页 > 详情页

Construction of Machine Learning Models to Predict Changes in Immune Function Using Clinical Monitoring Indices in HIV/AIDS Patients After 9.9-Years of Antiretroviral Therapy in Yunnan, China.

| 导出 | |

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China. [2]Department of Laboratory Medicine, Yunnan Provincial Institute of Infectious Diseases, Kunming, China. [3]Department of Laboratory Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, China. [4]Yunnan Key Laboratory of Laboratory Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, China. [5]Yunnan Innovation Team of Clinical Laboratory and Diagnosis, First Affiliated Hospital of Kunming Medical University, Kunming, China. [6]Department of Gynecology, First Affiliated Hospital of Kunming Medical University, Kunming, China. [7]Department of Medical Records and Statistics, First Affiliated Hospital of Kunming Medical University, Kunming, China. [8]Department of Disease Control and Prevention, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China. [9]National Health Commission (NHC) Key Laboratory of Drug Addiction Medicine, First Affiliated Hospital of Kunming Medical University, Kunming Medical University, Kunming, China. [10]Scientific Research Laboratory Center, First Affiliated Hospital of Kunming Medical University, Kunming, China.
出处:
ISSN:

关键词: HIV/AIDS RF MLP SVM machine learning model CD4/CD8 ratio prediction ART

摘要:
To investigate trends in clinical monitoring indices in HIV/AIDS patients receiving antiretroviral therapy (ART) at baseline and after treatment in Yunnan Province, China and to provide the basis for guiding clinical treatment to obtain superior clinical outcomes.A total of 96 HIV/AIDS patients who had started and persisted in highly active ART treatment from September 2009 to September 2019 were selected. Of these, 54 had a CD4 cell count < 200 cells/μl while 42 had a CD4 cell count ≥ 200 cells/μl. Routine blood tests, liver and renal function, and lipid levels were measured before and 3, 6, 9, and 12 months after treatment. Lymphocyte subset counts and viral load were measured once per year, and recorded for analysis and evaluation. Three machine learning models (support vector machine [SVM], random forest [RF], and multi-layer perceptron [MLP]) were constructed that used the clinical indicators above as parameters. Baseline and follow-up results of routine blood and organ function tests were used to analyze and predict CD4+ T cell data after treatment during long-term follow-up. Predictions of the three models were preliminarily evaluated.There were no statistical differences in gender, age, or HIV transmission route in either patient group. Married individuals were substantially more likely to have <200 CD4+ cells/μl. There was a strong positive correlation between ALT and AST (r = 0.587) and a positive correlation between CD4 cell count and platelet count (r = 0.347). Platelet count was negatively correlated with ALT (r = -0.229), AST (r = -0.251), and positively correlated with WBCs (r = 0.280). Compared with the CD4 cell count < 200 cells/μl group, all three machine learning models exhibited a better predictive capability than for patients with a CD4 cell count ≥ 200 cells/μl. Of all indicators, the three models best predicted the CD4/CD8 ratio, with results that were highly consistent. In patients with a CD4 cell count < 200 cells/μl, the SVM model had the best performance for predicting the CD4/CD8 ratio, while the CD4/CD8 ratio was best predicted by the RF model in patients with a CD4 cell count ≥ 200 cells/μl.By the incorporation of clinical indicators in SVM, RF, and MLP machine learning models, the immune function and recuperation of HIV/AIDS patients can be predicted and evaluated, thereby better guiding clinical treatment.Copyright © 2022 Li, Li, Song, Lu, Liu, He, Zhang, Wan, Zhang, Sun, Kuang and Li.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 2 区 医学
小类 | 2 区 微生物学 3 区 免疫学
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 微生物学 3 区 免疫学
JCR分区:
出版当年[2022]版:
Q1 MICROBIOLOGY Q2 IMMUNOLOGY
最新[2023]版:
Q1 MICROBIOLOGY Q2 IMMUNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.
共同第一作者:
通讯作者:
通讯机构: [3]Department of Laboratory Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, China. [4]Yunnan Key Laboratory of Laboratory Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, China. [5]Yunnan Innovation Team of Clinical Laboratory and Diagnosis, First Affiliated Hospital of Kunming Medical University, Kunming, China. [9]National Health Commission (NHC) Key Laboratory of Drug Addiction Medicine, First Affiliated Hospital of Kunming Medical University, Kunming Medical University, Kunming, China. [10]Scientific Research Laboratory Center, First Affiliated Hospital of Kunming Medical University, Kunming, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:53617 今日访问量:17 总访问量:1665 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)